Portera C A, Love E J, Memore L, Zhang L, Müller A, Browder W, Williams D L
Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City 37614-0575, USA.
Am Surg. 1997 Feb;63(2):125-31.
Immunomodulators that enhance macrophage function have been shown to be beneficial in a number of wound-healing models in humans and in experimental animals. The exact mechanism of this improved healing is unclear. To assess the role of collagen biosynthesis, the immunomodulator glucan phosphate was utilized in two murine models of wound healing, i.e., colon anastomosis and full-thickness skin incision. Tensile strength was evaluated using computer-assisted constant velocity tensiometry. Collagen biosynthesis was determined by assaying hydroxyproline content of wound hydrolysates by N-(9-fluorenyl)methoxycarbonyl/o-phthalaldehyde high-performance liquid chromatography. Experimental animals were treated with (1-3)-beta-D-glucan phosphate (250 mg/kg) intravenously 24 hours prior to colon anastomosis or skin incision. A second dose of glucan phosphate was given immediately postoperatively. Control animals received dextrose and water (5% w/v) intravenously. Tensile strength and hydroxyproline content were measured on postoperative Day 3. In the skin wound model, glucan phosphate treatment increased (P < 0.05) tensile strength by 42 per cent (342.5 +/- 12.2 vs 241.8 +/- 4.8 g), and hydroxyproline content was increased by 23.5 per cent (242.0 +/- 14.4 vs 196.8 +/- 10.5 pmol/microg; P < 0.05). In the glucan phosphate group, colon tensile strength was significantly (P < 0.05) increased by 34 per cent (34.2 +/- 2.3 g vs 45.8 +/- 2.1 g), and hydroxyproline content was increased by 7 per cent (47.45 +/- 3.31 vs 44.34 +/- 3.74 pmol/microg). These data indicate that macrophage modulation with glucan phosphate will increase tensile strength in experimental colon and skin wounds. In addition, we observed a positive correlation between glucan phosphate treatment, wound tensile strength, and collagen biosynthesis.
已证明,增强巨噬细胞功能的免疫调节剂在人类和实验动物的多种伤口愈合模型中具有益处。这种改善愈合的确切机制尚不清楚。为了评估胶原蛋白生物合成的作用,在两种小鼠伤口愈合模型(即结肠吻合术和全层皮肤切口)中使用了免疫调节剂磷酸葡聚糖。使用计算机辅助恒速张力测定法评估拉伸强度。通过N-(9-芴基)甲氧基羰基/邻苯二甲醛高效液相色谱法测定伤口水解产物中的羟脯氨酸含量来确定胶原蛋白生物合成。在结肠吻合术或皮肤切口前24小时,给实验动物静脉注射(1-3)-β-D-磷酸葡聚糖(250mg/kg)。术后立即给予第二剂磷酸葡聚糖。对照动物静脉注射葡萄糖和水(5%w/v)。在术后第3天测量拉伸强度和羟脯氨酸含量。在皮肤伤口模型中,磷酸葡聚糖治疗使拉伸强度提高了42%(P <0.05)(342.5±12.2对241.8±4.8g),羟脯氨酸含量增加了23.5%(242.0±14.4对196.8±10.5pmol/μg;P <0.05)。在磷酸葡聚糖组中,结肠拉伸强度显著提高(P <0.05)34%(34.2±2.3g对45.8±2.1g),羟脯氨酸含量增加了7%(47.45±3.31对44.34±3.74pmol/μg)。这些数据表明,用磷酸葡聚糖调节巨噬细胞将增加实验性结肠和皮肤伤口的拉伸强度。此外,我们观察到磷酸葡聚糖治疗、伤口拉伸强度和胶原蛋白生物合成之间存在正相关。